Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Igor T Gavrilovic

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
The Oncologist|April 12, 2013
In replyAlyx C Rosen, Igor T Gavrilovic, Yevgeniy Balagula, et al.
Journal of Neuro-Oncology|November 8, 2007
A phase II trial of vinorelbine and intensive temozolomide for patients with recurrent or progressive brain metastasesFabio M Iwamoto, Antonio M Omuro, Jeffrey J Raizer, et al.
Journal of Neuro-Oncology|July 21, 2019
Phase II trial of an AKT inhibitor (perifosine) for recurrent glioblastomaThomas J Kaley, Katherine S Panageas, Ingo K Mellinghoff, et al.
Neurology|August 10, 2022
Combination Olaparib and Temozolomide for the Treatment of Glioma: A Retrospective Case SeriesLauren R Schaff, Marina Kushnirsky, Andrew L Lin, et al.
Blood|January 9, 2015
R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphomaAntonio Omuro, Denise D Correa, Lisa M DeAngelis, et al.
BMC Cancer|January 14, 2022
Routine use of low-dose glucarpidase following high-dose methotrexate in adult patients with CNS lymphoma: an open-label, multi-center phase I studyLauren R Schaff, Mina Lobbous, Dean Carlow, et al.
Neuro-Oncology Practice|May 11, 2026
Outcomes of inpatient chemoradiotherapy for patients with newly diagnosed glioblastoma and significant functional impairmentNeil Sielski, Anne S Reiner, William E Rosa, et al.
Neuro-Oncology|December 18, 2012
Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant gliomaAntonio Omuro, Timothy A Chan, Lauren E Abrey, et al.
JCO Precision Oncology|February 25, 2026
Noninvasive Identification of Isocitrate Dehydrogenase 1/2 Mutation in Brainstem GliomasMarina Kushnirsky, Andrew L Lin, Tejus Bale, et al.
Neuro-Oncology|January 20, 2026
Ibrutinib in combination with rituximab, methotrexate, vincristine, and procarbazine (R-MVP/i) for newly diagnosed primary CNS lymphoma (PCNSL)Lauren R Schaff, Elena Pentsova, Rachna Malani, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
The Oncologist|April 12, 2013
In replyAlyx C Rosen, Igor T Gavrilovic, Yevgeniy Balagula, et al.
Journal of Neuro-Oncology|November 8, 2007
A phase II trial of vinorelbine and intensive temozolomide for patients with recurrent or progressive brain metastasesFabio M Iwamoto, Antonio M Omuro, Jeffrey J Raizer, et al.
Journal of Neuro-Oncology|July 21, 2019
Phase II trial of an AKT inhibitor (perifosine) for recurrent glioblastomaThomas J Kaley, Katherine S Panageas, Ingo K Mellinghoff, et al.
Neurology|August 10, 2022
Combination Olaparib and Temozolomide for the Treatment of Glioma: A Retrospective Case SeriesLauren R Schaff, Marina Kushnirsky, Andrew L Lin, et al.
Blood|January 9, 2015
R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphomaAntonio Omuro, Denise D Correa, Lisa M DeAngelis, et al.
BMC Cancer|January 14, 2022
Routine use of low-dose glucarpidase following high-dose methotrexate in adult patients with CNS lymphoma: an open-label, multi-center phase I studyLauren R Schaff, Mina Lobbous, Dean Carlow, et al.
Neuro-Oncology Practice|May 11, 2026
Outcomes of inpatient chemoradiotherapy for patients with newly diagnosed glioblastoma and significant functional impairmentNeil Sielski, Anne S Reiner, William E Rosa, et al.
Neuro-Oncology|December 18, 2012
Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant gliomaAntonio Omuro, Timothy A Chan, Lauren E Abrey, et al.
JCO Precision Oncology|February 25, 2026
Noninvasive Identification of Isocitrate Dehydrogenase 1/2 Mutation in Brainstem GliomasMarina Kushnirsky, Andrew L Lin, Tejus Bale, et al.
Neuro-Oncology|January 20, 2026
Ibrutinib in combination with rituximab, methotrexate, vincristine, and procarbazine (R-MVP/i) for newly diagnosed primary CNS lymphoma (PCNSL)Lauren R Schaff, Elena Pentsova, Rachna Malani, et al.
Pageof 3